Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2013

Feb 27, 2013

5229_dirs_2013-02-27_e55e5499-a86d-41c3-bf21-322b0104e09d.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7732Y

AstraZeneca PLC

27 February 2013

Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 25 February 2013, the following individuals, who are all persons discharging managerial responsibilities, acquired an interest in the USD0.25 Ordinary Shares or American Depositary Shares (ADSs) of AstraZeneca PLC.  One ADS equals one Ordinary Share.  The interest arises as a result of the previously disclosed arrangements relating to the payment of annual bonuses whereby each individual is required to defer a portion of the bonus earned into shares for a period of three years.  The shares are awarded under the terms of the AstraZeneca Deferred Bonus Plan.  The individuals will become beneficially entitled to these shares on 25 February 2016. Ordinary Shares were awarded at 2939 pence per share. ADSs were awarded at $45.01 per share.

Name Number of shares awarded
Katarina Ageborg 1,582
Jeff Pott 2,969
David Smith 1,934
Lynn Tetrault 2,450

A C N Kemp

Company Secretary

27 February 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUBAKROKAUURR